Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).
Chauvel
P
P
Centre Antoine-Lacassagne-Cyclotron Biomédical, Nice, France.
Sauerwein
W
W
Bornfeld
N
N
Friedrichs
W
W
Brassart
N
N
Courdi
A
A
Hérault
J
J
Pignol
J P
JP
Bondiau
P Y
PY
Malandain
G
G
D003230:Conjunctival Neoplasms / Q000175:diagnosis / Q000532:radiotherapy; D004307:Dose-Response Relationship, Radiation; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000175:diagnosis / Q000532:radiotherapy*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011237:Predictive Value of Tests; D061766:Proton Therapy; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014604:Uveal Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D011522:Protons
D011522:Protons